Sheri L. Snow is an author at Pfizer (United States) specializing in medicine, pharmacology, and medicinal chemistry.
Top concepts
MedicinePharmacologyDrug DiscoveryMedicinal ChemistryBiochemistryDrug DevelopmentNatural SciencesBiological ActivityGlycobiologyIon Channels
Publications per year
2002–2015
7
7
Blaise Lippa, Joel Morris, Matthew S. Corbett et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text
Medicinal Chemistry, Drug Target, Novel Isothiazole Inhibitors +10
Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13
Mark C. Noe, Vijayalakshmi Natarajan, Sheri L. Snow et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 44 citations · Full text
Medicinal Chemistry, Medicine, 3,3-Dimethyl-5-hydroxypipecolic Hydroxamate-based Inhibitors +4
Michael A. Letavic, John T. Barberia, Thomas J. Carty et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 40 citations · Full text
Biological Activity, Molecular Pharmacology, Medicinal Chemistry +9
Mark C. Noe, Vijayalakshmi Natarajan, Sheri L. Snow et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 37 citations · Full text
Medicinal Chemistry, 3-Oh-3-methylpipecolic Hydroxamates, Pharmaceutical Science +10
Rows per page
1–5 of 7